These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 25336642)

  • 1. Cancer metabolism and elevated O-GlcNAc in oncogenic signaling.
    Ma Z; Vosseller K
    J Biol Chem; 2014 Dec; 289(50):34457-65. PubMed ID: 25336642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAc in cancer biology.
    Ma Z; Vosseller K
    Amino Acids; 2013 Oct; 45(4):719-33. PubMed ID: 23836420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Essential role of O-GlcNAcylation in stabilization of oncogenic factors.
    Makwana V; Ryan P; Patel B; Dukie SA; Rudrawar S
    Biochim Biophys Acta Gen Subj; 2019 Aug; 1863(8):1302-1317. PubMed ID: 31034911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAc signaling in cancer metabolism and epigenetics.
    Singh JP; Zhang K; Wu J; Yang X
    Cancer Lett; 2015 Jan; 356(2 Pt A):244-50. PubMed ID: 24769077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy.
    Lu Q; Zhang X; Liang T; Bai X
    Mol Med; 2022 Sep; 28(1):115. PubMed ID: 36104770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
    Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential coordination role between O-GlcNAcylation and epigenetics.
    Wu D; Cai Y; Jin J
    Protein Cell; 2017 Oct; 8(10):713-723. PubMed ID: 28488246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feedback Regulation of
    Lin CH; Liao CC; Chen MY; Chou TY
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.
    Lynch TP; Ferrer CM; Jackson SR; Shahriari KS; Vosseller K; Reginato MJ
    J Biol Chem; 2012 Mar; 287(14):11070-81. PubMed ID: 22275356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. O-GlcNAc signaling: a metabolic link between diabetes and cancer?
    Slawson C; Copeland RJ; Hart GW
    Trends Biochem Sci; 2010 Oct; 35(10):547-55. PubMed ID: 20466550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of O-GlcNAc modification in cancer epigenetics.
    Forma E; Jóźwiak P; Bryś M; Krześlak A
    Cell Mol Biol Lett; 2014 Sep; 19(3):438-60. PubMed ID: 25141978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
    Zhang N; Chen X
    Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [O-GlcNAc glycosylation and regulation of cell signaling].
    Issad T
    Med Sci (Paris); 2010; 26(8-9):753-9. PubMed ID: 20819714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAc modification affects the ATM-mediated DNA damage response.
    Miura Y; Sakurai Y; Endo T
    Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cancer metabolism by O-GlcNAcylation.
    Li Z; Yi W
    Glycoconj J; 2014 Apr; 31(3):185-91. PubMed ID: 24323367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On a sugar high: Role of O-GlcNAcylation in cancer.
    Le Minh G; Esquea EM; Young RG; Huang J; Reginato MJ
    J Biol Chem; 2023 Nov; 299(11):105344. PubMed ID: 37838167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-GlcNAcylation in tumorigenesis and its implications for cancer therapy.
    Zhang D; Qi Y; Inuzuka H; Liu J; Wei W
    J Biol Chem; 2024 Sep; 300(9):107709. PubMed ID: 39178944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-GlcNAc modification, insulin signaling and diabetic complications.
    Issad T; Masson E; Pagesy P
    Diabetes Metab; 2010 Dec; 36(6 Pt 1):423-35. PubMed ID: 21074472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross regulation between mTOR signaling and O-GlcNAcylation.
    Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
    J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.
    Ma Z; Vocadlo DJ; Vosseller K
    J Biol Chem; 2013 May; 288(21):15121-30. PubMed ID: 23592772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.